Rani Therapeutics Holdings, Inc.
RANI
$1.05
-$0.05-4.55%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.46M | -- | -- | 172.00K | 1.03M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.46M | -- | -- | 172.00K | 1.03M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 1.46M | -- | -- | 172.00K | 1.03M |
| SG&A Expenses | 5.09M | 4.04M | 5.00M | 5.62M | 5.46M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.00M | 7.26M | 10.51M | 12.19M | 12.27M |
| Operating Income | -8.54M | -7.26M | -10.51M | -12.01M | -11.24M |
| Income Before Tax | -9.07M | -7.91M | -11.22M | -12.74M | -15.72M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.07M | -7.91M | -11.22M | -12.74M | -15.72M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.23M | 2.50M | 4.53M | 5.47M | 6.78M |
| Net Income | -10.31M | -5.41M | -6.69M | -7.26M | -8.95M |
| EBIT | -8.54M | -7.26M | -10.51M | -12.01M | -11.24M |
| EBITDA | -8.35M | -7.03M | -10.27M | -11.76M | -10.98M |
| EPS Basic | -0.07 | -0.12 | -0.18 | -0.22 | -0.27 |
| Normalized Basic EPS | -0.04 | -0.05 | -0.07 | -0.07 | -0.02 |
| EPS Diluted | -0.14 | -0.12 | -0.18 | -0.22 | -0.27 |
| Normalized Diluted EPS | -0.04 | -0.05 | -0.07 | -0.07 | -0.02 |
| Average Basic Shares Outstanding | 147.09M | 46.44M | 36.54M | 33.44M | 32.66M |
| Average Diluted Shares Outstanding | 147.09M | 46.44M | 36.54M | 33.44M | 32.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |